4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0000950170-24-094816
EVP, COO acquired 314 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lamothe Jeffrey G. EVP, COO | 2024-08-08 | Option exercise | +42 | 894 | D | ||
| Lamothe Jeffrey G. EVP, COO | 2024-08-08 | Option exercise | +272 | 1,166 | D | ||
| Derivatives | |||||||
| Lamothe Jeffrey G. EVP, COO | 2024-08-08 | Option exercise · Restricted Stock Unit | −42 | 41 | D | ||
| Lamothe Jeffrey G. EVP, COO | 2024-08-08 | Option exercise · Restricted Stock Unit | −272 | 0 | D | ||
Loading xslF345X05/ownership.xml…